Effects of antiviral therapy on the cellular immune response in patients with chronic hepatitis B

Luo,Guangcheng; Feng,Xia; Huang,Yanxiang; Yi,Tingting; Wang,Dongsheng; Guo,Xiaolan; Yan,Huiping; Zhang,Guoyuan

doi:10.3892/mmr.2014.2836

February-2015 Volume 11 Issue 2

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

February-2015 Volume 11 Issue 2

Full Size Image

Article

Effects of antiviral therapy on the cellular immune response in patients with chronic hepatitis B

Authors:
- Guangcheng Luo
- Xia Feng
- Yanxiang Huang
- Tingting Yi
- Dongsheng Wang
- Xiaolan Guo
- Huiping Yan
- Guoyuan Zhang
View Affiliations / Copyright

Affiliations: Department of Clinical Laboratory, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan 637000, P.R. China, Research Center for Infection and Immunity, Beijing You'an Hospital, Capital Medical University, Beijing 100069, P.R. China
Pages: 1284-1291
|
Published online on: October 31, 2014

https://doi.org/10.3892/mmr.2014.2836
Expand metrics +

Abstract

A weak T‑cell immune response to the hepatitis B virus (HBV) is hypothesized to be the primary cause of chronic HBV infection. Emerging evidence suggests that long‑term effective antiviral therapy restores the HBV‑specific T‑cell response from exhaustion. However, the extent to which the cellular immune response can be restored following the persistent suppression of HBV replication by antiviral therapy remains unclear. In order to investigate this question, 46 patients with chronic hepatitis B (CHB) treated with nucleos(t)ide analogues who demonstrated persistent suppression of HBV replication [defined as undetectable HBV DNA, hepatitis B e antigen (HBeAg) negative and adherence to antiviral therapy], 22 untreated CHB patients, 15 patients with acute hepatitis B (AHB) and 10 healthy adults were recruited. HBV‑specific interferon‑γ enzyme‑linked immunospot (IFN‑γ ELISPOT) assay and HBV‑specific T‑cell proliferation analysis were performed with a panel of overlapping peptides covering the envelope and core antigens. Data from this study showed that the HBV‑specific immune responses to the peptide pools of the envelope and core protein in the treated patients were stronger than those in the untreated CHB patients, but significantly weaker than those in the AHB patients and healthy adults. A higher frequency of response to S than C peptide pools was confirmed by the IFN‑γ ELISPOT assay in the treated CHB patients. The restoration of antiviral immunity was clearly associated with a reduction in HBV DNA and the duration of HBV DNA suppression. In conclusion, the HBV‑specific immune responses in the CHB patients can be significantly restored from exhaustion following the persistent suppression of HBV replication as a result of antiviral treatment with nucleos(t)ide analogues.

View Figures

View References

1	Chao J, Song L, Zhang H, et al: Effects of comprehensive intervention on health-related quality of life in patients with chronic hepatitis B in China. BMC Health Serv Res. 13:3862013. View Article : Google Scholar : PubMed/NCBI
2	Jiang X, Zhang M, Lai Q, et al: Restored circulating invariant NKT cells are associated with viral control in patients with chronic hepatitis B. PLoS One. 6:e288712011. View Article : Google Scholar : PubMed/NCBI
3	Liaw YF: Impact of therapy on the outcome of chronic hepatitis B. Liver Int. 33(Suppl 1): 111–115. 2013. View Article : Google Scholar : PubMed/NCBI
4	Lam YF, Yuen MF, Seto WK and Lai CL: Current antiviral therapy of chronic hepatitis B: efficacy and safety. Curr Hepat Rep. 10:235–243. 2011. View Article : Google Scholar : PubMed/NCBI
5	Webster GJ, Reignat S, Brown D, et al: Longitudinal analysis of CD8+ T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B: implications for immunotherapy. J Virol. 78:5707–5719. 2004. View Article : Google Scholar : PubMed/NCBI
6	Ribeiro RM, Germanidis G, Powers KA, et al: Hepatitis B virus kinetics under antiviral therapy sheds light on differences in hepatitis B e antigen positive and negative infections. J Infect Dis. 202:1309–1318. 2010. View Article : Google Scholar : PubMed/NCBI
7	Carey I, D’Antiga L, Bansal S, et al: Immune and viral profile from tolerance to hepatitis B surface antigen clearance: a longitudinal study of vertically hepatitis B virus-infected children on combined therapy. J Virol. 85:2416–2428. 2011. View Article : Google Scholar :
8	Liang M, Ma S, Hu X, et al: Cellular immune responses in patients with hepatitis B surface antigen seroclearance induced by antiviral therapy. Virol J. 8:692011. View Article : Google Scholar : PubMed/NCBI
9	Boni C, Fisicaro P, Valdatta C, et al: Characterization of hepatitis B virus (HBV)-specific T-cell dysfunction in chronic HBV infection. J Virol. 81:4215–4225. 2007. View Article : Google Scholar : PubMed/NCBI
10	Boni C, Laccabue D, Lampertico P, et al: Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology. 143:963–973. 2012. View Article : Google Scholar : PubMed/NCBI
11	Jiang Y, Ma Z, Xin G, et al: Th1 and Th2 immune response in chronic hepatitis B patients during a long-term treatment with adefovir dipivoxil. Mediators Inflamm. 2010:1430262010. View Article : Google Scholar : PubMed/NCBI
12	Rico MA, Quiroga JA, Subirá D, et al: Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha. Hepatology. 33:295–300. 2001. View Article : Google Scholar
13	Tsai SL, Sheen IS, Chien RN, et al: Activation of Th1 immunity is a common immune mechanism for the successful treatment of hepatitis B and C: tetramer assay and therapeutic implications. J Biomed Sci. 10:120–135. 2003. View Article : Google Scholar : PubMed/NCBI
14	Chen Y, Li X, Ye B, et al: Effect of telbivudine therapy on the cellular immune response in chronic hepatitis B. Antiviral Res. 91:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
15	Janssen EM, Lemmens EE, Wolfe T, et al: CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature. 421:852–856. 2003. View Article : Google Scholar : PubMed/NCBI
16	Li X, Chen Y, Ma Z, et al: Effect of regulatory T cells and adherent cells on the expansion of HBcAg-specific CD8+ T cells in patients with chronic hepatitis B virus infection. Cell Immunol. 264:42–46. 2010. View Article : Google Scholar : PubMed/NCBI
17	Stoop JN, van der Molen RG, Kuipers EJ, et al: Inhibition of viral replication reduces regulatory T cells and enhances the antiviral immune response in chronic hepatitis B. Virology. 361:141–148. 2007. View Article : Google Scholar
18	Wherry EJ, Blattman JN and Ahmed R: Low CD8 T-cell proliferative potential and high viral load limit the effectiveness of therapeutic vaccination. J Virol. 79:8960–8968. 2005. View Article : Google Scholar : PubMed/NCBI
19	Thimme R, Wieland S, Steiger C, et al: CD8(+) T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol. 77:68–76. 2003. View Article : Google Scholar :
20	Maini MK, Boni C, Lee CK, et al: The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med. 191:1269–1280. 2000. View Article : Google Scholar : PubMed/NCBI

Journals

International Journal of Molecular Medicine

International Journal of Oncology

Molecular Medicine Reports

Oncology Reports

Experimental and Therapeutic Medicine

Oncology Letters

Biomedical Reports

Molecular and Clinical Oncology

World Academy of Sciences Journal

International Journal of Functional Nutrition

International Journal of Epigenetics

Medicine International

Effects of antiviral therapy on the cellular immune response in patients with chronic hepatitis B

This article is mentioned in:

Abstract

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Related Articles